Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,006,904
-$4,092,510 QoQ
Shares Held
32,086
+2.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#214
of 1,322 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ING GROEP NV holds $202,433,197 across 10 Biotechnology names. REGN ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
223,124 | $110,832,384 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
32,086 | $20,006,904 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
564,600 | $19,981,194 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
103,000 | $19,289,840 | |
| 5 | EXEL |
Exelixis, Inc.
|
311,400 | $16,943,274 | |
| 6 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
12,244 | $2,950,436 | |
| 8 | INCY |
Incyte Corp
|
20,633 | $2,338,956 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,006,904 | 32,086 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,099,414 | 31,191 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $43,685,526 | 56,597 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $61,218,270 | 108,877 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $24,217,200 | 46,128 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $13,528,760 | 21,331 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $20,718,118 | 29,085 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $22,876,033 | 21,761 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $5,318,211 | 5,060 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,282,714 | 27,307 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,865,268 | 28,311 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $29,457,853 | 35,795 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $23,527,155 | 32,743 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $26,978,712 | 32,834 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $19,973,007 | 27,683 | Shares | Defined | 2023-02-13 | |
| 2022-06-30 | $15,742,383 | 26,631 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $37,806,173 | 54,131 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,127,620 | 49,290 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,459,691 | 10,674 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $5,833,950 | 10,445 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $3,360,030 | 6,955 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,295,330 | 2,314 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $531,973 | 853 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $713,879 | 1,462 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||